Literature DB >> 34185373

Successful use of crushed formulation of dabrafenib and trametinib in a pediatric glioneural tumor.

Tania Mamdouhi1, Anshul Vagrecha2, Alan A Johnson1,3, Carolyn Fein Levy1,2, Mark Atlas1,2, Julie I Krystal1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34185373     DOI: 10.1002/pbc.29187

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  1 in total

1.  Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update.

Authors:  Richard H Parrish; Lisa D Ashworth; Raimar Löbenberg; Sandra Benavides; Jeffrey J Cies; Robert B MacArthur
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.